VCYT - CIK 0001384101
VERACYTE, INC. trades as VCYT and has a market capitalization of $3.89 B, making it the #1595 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $517.14M, up 16.0% from the prior year and net income of $66.40M. This page tracks VERACYTE, INC. through 1,126 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years VERACYTE, INC.'s revenue grew from $65.08M to $517.14M, a compound annual growth rate of 25.9%. Net profit margin expanded from -25.0% to 12.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-13 |
| SCHEDULE 13G | - | 2026-05-12 |
| Insider trade | 4 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-06 |
| SCHEDULE 13G/A | - | 2026-05-06 |
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings | Veracyte, Inc.
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer | Veracyte, Inc.
Veracyte to Participate in Upcoming Investor Conferences | Veracyte, Inc.
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer | Veracyte, Inc.
Veracyte Announces First Quarter 2026 Financial Results | Veracyte, Inc.
The largest companies sharing VERACYTE, INC.'s SEC industry classification (services-medical laboratories).
VERACYTE, INC. (VCYT) has a market capitalization of $3.89 B as of 2026-06-10, ranking #1595 among US-listed companies.
VERACYTE, INC. reported revenue of $517.14M for fiscal year 2025, an increase of 16.0% year over year.
Yes. VERACYTE, INC. reported net income of $66.40M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.